Xylem Inc.
XYL
$128.98
$1.140.89%
Weiss Ratings | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Reward Grade | B+ | |||
Rating Factors | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Weak | |||
Growth Index | Excellent | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.13 | |||
Price History | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.74% | |||
30-Day Total Return | 0.78% | |||
60-Day Total Return | 13.18% | |||
90-Day Total Return | 17.86% | |||
Year to Date Total Return | 11.90% | |||
1-Year Total Return | 21.92% | |||
2-Year Total Return | 52.61% | |||
3-Year Total Return | 15.64% | |||
5-Year Total Return | 56.40% | |||
52-Week High % Change | -1.44% | |||
52-Week Low % Change | 47.25% | |||
Price | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $130.86 | |||
52-Week Low Price | $87.59 | |||
52-Week Low Price (Date) | Oct 30, 2023 | |||
52-Week High Price (Date) | Mar 21, 2024 | |||
Valuation | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 30.91B | |||
Enterprise Value | 32.62B | |||
Price/Earnings (TTM) | 47.07 | |||
Earnings Per Share (TTM) | 2.72 | |||
Earnings Per Share Growth | 38.86% | |||
Price/Earnings To Growth | 1.22 | |||
Price/Sales (TTM) | 4.21 | |||
Price/Book (Q) | 3.04 | |||
Enterprise Value/Revenue (TTM) | 4.47 | |||
Price | $127.16 | |||
Enterprise Value/EBITDA (TTM) | 25.41 | |||
Enterprise Value/EBIT | 38.30 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 242.47M | |||
Dividend Yield | 1.06% | |||
Div. Per Share (Most Recent) | $0.36 | |||
Dividend Per Share (TTM) | $1.35 | |||
Payout Ratio (TTM) | 49.10% | |||
Dividend Per Share (Most Recent) | $0.36 | |||
Company Info | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 202 869 9150 | |||
Address | 300 Water Street SE Washington, DC 20003 | |||
Website | www.xylem.com | |||
Country | United States | |||
Year Founded | 2011 | |||
Profitability | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 11.66% | |||
Profit Margin | 8.26% | |||
Management Effectiveness | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 4.46% | |||
Return on Equity | 8.90% | |||
Income Statement | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 7.36B | |||
Total Revenue (TTM) | 7.36B | |||
Revenue Per Share | $30.37 | |||
Gross Profit (TTM) | 2.72B | |||
EBITDA (TTM) | 1.30B | |||
EBIT (TTM) | 859.00M | |||
Net Income (TTM) | 609.00M | |||
Net Income Avl. to Common (TTM) | 609.00M | |||
Total Revenue Growth (Q YOY) | 40.64% | |||
Earnings Growth (Q YOY) | 78.52% | |||
EPS Diluted (TTM) | 2.72 | |||
EPS Diluted Growth (Q YOY) | 34.06% | |||
Balance Sheet | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.02B | |||
Cash Per Share (Q) | $4.20 | |||
Total Current Assets (Q) | 3.88B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 10.18B | |||
Current Ratio (Q) | 1.761 | |||
Book Value Per Share (Q) | $42.09 | |||
Total Assets (Q) | 16.11B | |||
Total Current Liabilities (Q) | 2.21B | |||
Total Debt (Q) | 2.73B | |||
Total Liabilities (Q) | 5.94B | |||
Total Common Equity (Q) | 10.17B | |||
Cash Flow | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -628.00M | |||
Cash from Financing (TTM) | -157.00M | |||
Net Change in Cash (TTM) | 75.00M | |||
Levered Free Cash Flow (TTM) | 497.25M | |||
Cash from Operations (TTM) | 837.00M | |||